Authors:
PRESS OW
SHAN D
HOWELLCLARK J
EARY J
APPELBAUM FR
MATTHEWS D
KING DJ
HAINES AMR
HAMANN P
HINMAN L
SHOCHAT D
BERNSTEIN ID
Citation: Ow. Press et al., COMPARATIVE METABOLISM AND RETENTION OF I-125, Y-90, AND IN-111 RADIOIMMUNOCONJUGATES BY CANCER-CELLS, Cancer research, 56(9), 1996, pp. 2123-2129
Authors:
ANTONIW P
FARNSWORTH APH
TURNER A
HAINES AMR
MOUNTAIN A
MACKINTOSH J
SHOCHAT D
HUMM J
WELT S
OLD LJ
YARRANTON GT
KING DJ
Citation: P. Antoniw et al., RADIOIMMUNOTHERAPY OF COLORECTAL-CARCINOMA XENOGRAFTS IN NUDE-MICE WITH Y-90 A33 IGG AND TRI-FAB (TFM), British Journal of Cancer, 74(4), 1996, pp. 513-524
Authors:
OBOYLE KP
COLLETTI D
MAZUREK C
WANG Y
RAY SK
DIAMOND B
ROSENBLUM MG
EPSTEIN AL
SHOCHAT D
DUTCHER JP
WIERNIK PH
KLEIN RS
Citation: Kp. Oboyle et al., POTENTIATION OF ANTIPROLIFERATIVE EFFECTS OF MONOCLONAL-ANTIBODY LYM-1 AND IMMUNOCONJUGATE LYM-1-GELONIN ON HUMAN BURKITTS-LYMPHOMA CELLS WITH GAMMA-INTERFERON AND TUMOR-NECROSIS-FACTOR, Journal of immunotherapy with emphasis on tumor immunology, 18(4), 1995, pp. 221-230
Authors:
KOSTERINK JGW
DEJONGE MWA
SMIT EF
PIERS DA
KENGEN RAM
POSTMUS PE
SHOCHAT D
GROEN HJM
THE HT
DELEIJ L
Citation: Jgw. Kosterink et al., PHARMACOKINETICS AND SCINTIGRAPHY OF INDIUM-111-DTPA-MOC-31 IN SMALL-CELL LUNG-CARCINOMA, The Journal of nuclear medicine, 36(12), 1995, pp. 2356-2362
Authors:
KING DJ
ANTONIW P
OWENS RJ
ADAIR JR
HAINES AMR
FARNSWORTH APH
FINNEY H
LAWSON ADG
LYONS A
BAKER TS
BALDOCK D
MACKINTOSH J
GOFTON C
YARRANTON GT
MCWILLIAMS W
SHOCHAT D
LEICHNER PK
WELT S
OLD LJ
MOUNTAIN A
Citation: Dj. King et al., PREPARATION AND PRECLINICAL EVALUATION OF HUMANIZED A33 IMMUNOCONJUGATES FOR RADIOIMMUNOTHERAPY, British Journal of Cancer, 72(6), 1995, pp. 1364-1372
Authors:
BEELEY NRA
TURNER A
BOYCE BA
ANTONIW P
FARNSWORTH A
HAINES A
KING DJ
LOW D
MOUNTAIN A
MILLAR K
MILLICAN TA
RHIND SK
SHOCHAT D
ADAIR J
YARRANTON GT
Citation: Nra. Beeley et al., IMPROVED PHARMACOKINETICS OF Y-90 DELIVERY WITH MULTIVALENT FAB' FRAGMENTS, The Journal of nuclear medicine, 35(5), 1994, pp. 160000063-160000063
Authors:
KING DJ
TURNER A
FARNSWORTH APH
ADAIR JR
OWENS RJ
PEDLEY RB
BALDOCK D
PROUDFOOT KA
LAWSON ADG
BEELEY NRA
MILLAR K
MILLICAN TA
BOYCE BA
ANTONIW P
MOUNTAIN A
BEGENT RHJ
SHOCHAT D
YARRANTON GT
Citation: Dj. King et al., IMPROVED TUMOR TARGETING WITH CHEMICALLY CROSS-LINKED RECOMBINANT ANTIBODY FRAGMENTS, Cancer research, 54(23), 1994, pp. 6176-6185
Authors:
KUZEL T
ROSEN ST
ZIMMER AM
SILVERSTEIN EA
SPIES S
SALETAN SL
NORVITCH ME
BIRKHOFER M
SHOCHAT D
LOBUGLIO AF
MEREDITH R
KHAZAELI MB
POLANSKY A
HU E
CHEN D
LEE K
WATKINS K
Citation: T. Kuzel et al., A PHASE-I ESCALATING-DOSE SAFETY, DOSIMETRY AND EFFICACY STUDY OF RADIOLABELED MONOCLONAL-ANTIBODY LYM-1, Cancer biotherapy, 8(1), 1993, pp. 3-16
Authors:
MEREDITH R
KHAZAELI MB
PLOTT G
WHEELER R
RUSSELL C
SHOCHAT D
NORVITCH M
SALETAN S
LOBUGLIO A
Citation: R. Meredith et al., COMPARISON OF DIAGNOSTIC AND THERAPEUTIC DOSES OF I-131 LYM-1 IN PATIENTS WITH NON-HODGKINS-LYMPHOMA, Antibody immunoconjugates, and radiopharmaceuticals, 6(1), 1993, pp. 1-11